Marijuana legalization stalls globally: systemic barriers block reform despite 60%+ public support

Indigenous communities have used cannabis for millennia, yet Western legalization frameworks often erase these histories or reduce them to 'traditional knowledge' footnotes. The commodification of cannabis under legalization mirrors colonial patterns, where indigenous knowledge is appropriated for profit while communities face criminalization for traditional use. In the U.S., Native tribes like the Flandreau Santee Sioux have pioneered tribal cannabis economies, but federal obstruction persists, revealing systemic disregard for tribal sovereignty. The erasure of indigenous stewardship in cannabis cultivation also ignores sustainable practices that could inform regenerative agriculture.

Cannabis prohibition emerged from 20th-century racialized moral panics, with Harry Anslinger’s 1930s campaigns targeting Mexican immigrants and Black jazz musicians to consolidate white middle-class control. The 1971 Controlled Substances Act was shaped by Nixon’s political calculus to suppress anti-war and Black liberation movements, not public health. Alcohol prohibition’s repeal in 1933 offers a parallel: corporate consolidation followed, with Big Alcohol dominating the market. The current legalization stall echoes the 1970s decriminalization efforts that were rolled back by law enforcement and pharmaceutical lobbying.

Canada’s legalization model prioritized corporate licenses over social equity, leading to a market dominated by multinational firms like Canopy Growth, while Black and Indigenous entrepreneurs face systemic barriers. Uruguay’s state-regulated model, though imperfect, centers public health over profit, contrasting with the U.S. patchwork of state-level legalization. In Thailand, cannabis was decriminalized in 2022 but quickly re-regulated under corporate control, sparking protests from traditional healers. South Africa’s 2018 court ruling legalized personal use but left commercialization mired in bureaucratic hurdles, benefiting white-owned businesses.

Meta-analyses show cannabis legalization correlates with reduced opioid overdoses and no significant increase in youth use when paired with robust public health regulations. The endocannabinoid system’s role in homeostasis suggests cannabis could address chronic conditions like epilepsy and PTSD, yet research funding remains biased toward pharmaceutical alternatives. The 'gateway drug' hypothesis lacks empirical support, with most users transitioning to other substances at rates similar to non-users. However, unregulated markets still pose risks, as seen in synthetic cannabinoid outbreaks in Europe and the U.S.

Cannabis has been a sacrament in Rastafarian, Hindu, and certain African spiritual traditions, where its use is tied to communal rituals and divine connection. Artists like Bob Marley and Nina Simone linked cannabis to cultural resistance and creative liberation, framing it as a tool for decolonization. Modern 'stoner culture' often commodifies these spiritual roots, reducing cannabis to a recreational product devoid of its deeper meaning. Indigenous artists like Cannupa Hanska Luger critique the erasure of these traditions in mainstream legalization narratives.

If current trends persist, corporate cannabis will dominate 80% of the U.S. market by 2030, with social equity programs underfunded and racial disparities in licensing persisting. Scenario modeling suggests that without federal rescheduling, the black market will continue to thrive, fueling cartels and unregulated products. Climate change may disrupt cannabis cultivation in traditional growing regions, necessitating investment in indoor and regenerative farming. A 'public option' model, like Canada’s proposed Crown corporation, could counter corporate capture but faces political resistance.

Black and Latino communities, disproportionately impacted by cannabis arrests, are systematically excluded from legal markets due to high licensing fees and zoning laws. Indigenous growers in the U.S. and Canada face federal raids despite state legality, while tribal cannabis economies struggle under jurisdictional conflicts. Low-income patients, many from marginalized backgrounds, are priced out of medical cannabis by corporate monopolies. Grassroots organizations like the Last Prisoner Project and Equity First Alliance highlight how legalization without expungement and reinvestment perpetuates harm.